Click here to get full coverage on Dynavax Technologies (NASDAQ:DVAX) Reaches New 52-Week Low - Here's What Happened - MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Reaches New 52-Week Low - Here's What Happened  MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Reaches New 52-Week Low - Here's What Happened - MarketBeat

Click here to get full coverage on Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PR Newswire

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs  PR Newswire

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PR Newswire

Click here to get full coverage on Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Yahoo Finance

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook  Yahoo Finance

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Yahoo Finance

Click here to get full coverage on Dynavax Technologies: A Dip To Accumulate (NASDAQ:DVAX) - Seeking Alpha

Dynavax Technologies: A Dip To Accumulate (NASDAQ:DVAX)  Seeking Alpha

Dynavax Technologies: A Dip To Accumulate (NASDAQ:DVAX) - Seeking Alpha

Click here to get full coverage on $DVAX stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$DVAX stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$DVAX stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Dynavax Technologies Corporation $DVAX Shares Purchased by Woodline Partners LP - MarketBeat

Dynavax Technologies Corporation $DVAX Shares Purchased by Woodline Partners LP  MarketBeat

Dynavax Technologies Corporation $DVAX Shares Purchased by Woodline Partners LP - MarketBeat

Click here to get full coverage on Is Dynavax Technologies' (DVAX) Raised HEPLISAV-B Guidance Reshaping Its Investment Narrative? - simplywall.st

Is Dynavax Technologies' (DVAX) Raised HEPLISAV-B Guidance Reshaping Its Investment Narrative?  simplywall.st

Is Dynavax Technologies' (DVAX) Raised HEPLISAV-B Guidance Reshaping Its Investment Narrative? - simplywall.st

Click here to get full coverage on Dynavax Files Preliminary Proxy Statement - PR Newswire

Dynavax Files Preliminary Proxy Statement  PR Newswire

Dynavax Files Preliminary Proxy Statement - PR Newswire

Click here to get full coverage on Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 - Yahoo Finance

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31  Yahoo Finance

Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 - Yahoo Finance

Click here to get full coverage on Dynavax Technologies Stock (DVAX) Opinions on Shingles Vaccine Trial Results | DVAX Stock News - Quiver Quantitative

Dynavax Technologies Stock (DVAX) Opinions on Shingles Vaccine Trial Results | DVAX Stock News  Quiver Quantitative

Dynavax Technologies Stock (DVAX) Opinions on Shingles Vaccine Trial Results | DVAX Stock News - Quiver Quantitative

Click here to get full coverage on Dynavax Technologies (NASDAQ:DVAX) shareholders are up 5.3% this past week, but still in the red over the last three years - simplywall.st

Dynavax Technologies (NASDAQ:DVAX) shareholders are up 5.3% this past week, but still in the red over the last three years  simplywall.st

Dynavax Technologies (NASDAQ:DVAX) shareholders are up 5.3% this past week, but still in the red over the last three years - simplywall.st

Click here to get full coverage on Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase - PR Newswire

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase  PR Newswire

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase - PR Newswire

Click here to get full coverage on Jacobs Levy Equity Management Inc. Buys New Position in Dynavax Technologies Corporation $DVAX - MarketBeat

Jacobs Levy Equity Management Inc. Buys New Position in Dynavax Technologies Corporation $DVAX  MarketBeat

Jacobs Levy Equity Management Inc. Buys New Position in Dynavax Technologies Corporation $DVAX - MarketBeat

Click here to get full coverage on Insider Sale: 10% owner at $DVAX Sells 1,094,994 Shares | DVAX Stock News - Quiver Quantitative

Insider Sale: 10% owner at $DVAX Sells 1,094,994 Shares | DVAX Stock News  Quiver Quantitative

Insider Sale: 10% owner at $DVAX Sells 1,094,994 Shares | DVAX Stock News - Quiver Quantitative

Click here to get full coverage on Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates  Yahoo Finance

Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Click here to get full coverage on Dynavax Advances Board Refreshment Program - PR Newswire

Dynavax Advances Board Refreshment Program  PR Newswire

Dynavax Advances Board Refreshment Program - PR Newswire

Click here to get full coverage on Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why  Yahoo Finance

Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Uniplan Investment Counsel Inc. Makes New $475,000 Investment in Dynavax Technologies Corporation $DVAX - MarketBeat

Uniplan Investment Counsel Inc. Makes New $475,000 Investment in Dynavax Technologies Corporation $DVAX  MarketBeat

Uniplan Investment Counsel Inc. Makes New $475,000 Investment in Dynavax Technologies Corporation $DVAX - MarketBeat

Click here to get full coverage on Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference - PR Newswire

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference  PR Newswire

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference - PR Newswire

Click here to get full coverage on Dynavax Announces $100 Million Accelerated Share Repurchase Program - PR Newswire

Dynavax Announces $100 Million Accelerated Share Repurchase Program  PR Newswire

Dynavax Announces $100 Million Accelerated Share Repurchase Program - PR Newswire

Click here to get full coverage on Dynavax Adopts Limited-Duration Stockholder Rights Plan - PR Newswire

Dynavax Adopts Limited-Duration Stockholder Rights Plan  PR Newswire

Dynavax Adopts Limited-Duration Stockholder Rights Plan - PR Newswire

Click here to get full coverage on Vaccine Developer Dynavax to Showcase HEPLISAV-B and COVID-19 Programs at Wells Fargo Conference - Stock Titan

Vaccine Developer Dynavax to Showcase HEPLISAV-B and COVID-19 Programs at Wells Fargo Conference  Stock Titan

Vaccine Developer Dynavax to Showcase HEPLISAV-B and COVID-19 Programs at Wells Fargo Conference - Stock Titan

Click here to get full coverage on Dynavax says shingles shot on par with GSK’s Shingrix (DVAX) - Seeking Alpha

Dynavax says shingles shot on par with GSK’s Shingrix (DVAX)  Seeking Alpha

Dynavax says shingles shot on par with GSK’s Shingrix (DVAX) - Seeking Alpha

Click here to get full coverage on Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - simplywall.st

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts  simplywall.st

Dynavax Technologies Corporation Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - simplywall.st

Click here to get full coverage on Dynavax Earnings: Vaccine Maker to Report Q2 Results as HEPLISAV-B Sales Growth Continues - Stock Titan

Dynavax Earnings: Vaccine Maker to Report Q2 Results as HEPLISAV-B Sales Growth Continues  Stock Titan

Dynavax Earnings: Vaccine Maker to Report Q2 Results as HEPLISAV-B Sales Growth Continues - Stock Titan

Click here to get full coverage on 100% Response Rate: Dynavax's New Shingles Vaccine Shows Lower Side Effects Than Market Leader Shingrix - Stock Titan

100% Response Rate: Dynavax's New Shingles Vaccine Shows Lower Side Effects Than Market Leader Shingrix  Stock Titan

100% Response Rate: Dynavax's New Shingles Vaccine Shows Lower Side Effects Than Market Leader Shingrix - Stock Titan

Click here to get full coverage on Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return - Stock Titan

Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return  Stock Titan

Dynavax Defends $900M Growth Strategy Against Activist's Push for Quick Cash Return - Stock Titan

Click here to get full coverage on Dynavax Technologies Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Dynavax Technologies Second Quarter 2025 Earnings: Beats Expectations  simplywall.st

Dynavax Technologies Second Quarter 2025 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on Dynavax Technologies (DVAX): Evaluating Valuation After Promising Phase 1/2 Shingles Vaccine Results - simplywall.st

Dynavax Technologies (DVAX): Evaluating Valuation After Promising Phase 1/2 Shingles Vaccine Results  simplywall.st

Dynavax Technologies (DVAX): Evaluating Valuation After Promising Phase 1/2 Shingles Vaccine Results - simplywall.st

Click here to get full coverage on Dynavax Showcases Commercial Vaccine Pipeline at Major William Blair Conference: Key Updates Coming - Stock Titan

Dynavax Showcases Commercial Vaccine Pipeline at Major William Blair Conference: Key Updates Coming  Stock Titan

Dynavax Showcases Commercial Vaccine Pipeline at Major William Blair Conference: Key Updates Coming - Stock Titan

Click here to get full coverage on Recent 6.5% Pullback Isn't Enough to Hurt Long-term Dynavax Technologies (NASDAQ:DVAX) Shareholders, They're Still up 73% Over 5 Years - 富途牛牛

Recent 6.5% Pullback Isn't Enough to Hurt Long-term Dynavax Technologies (NASDAQ:DVAX) Shareholders, They're Still up 73% Over 5 Years  富途牛牛

Recent 6.5% Pullback Isn't Enough to Hurt Long-term Dynavax Technologies (NASDAQ:DVAX) Shareholders, They're Still up 73% Over 5 Years - 富途牛牛

Click here to get full coverage on Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6 - Stock Titan

Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6  Stock Titan

Dynavax Q1 Earnings: Vaccine Maker to Reveal Latest HEPLISAV-B Performance on May 6 - Stock Titan

Click here to get full coverage on Trexquant Investment LP Decreases Stock Holdings in Dynavax Technologies Corporation $DVAX - MarketBeat

Trexquant Investment LP Decreases Stock Holdings in Dynavax Technologies Corporation $DVAX  MarketBeat

Trexquant Investment LP Decreases Stock Holdings in Dynavax Technologies Corporation $DVAX - MarketBeat

Click here to get full coverage on American Century Companies Inc. Buys 30,081 Shares of Dynavax Technologies Corporation $DVAX - MarketBeat

American Century Companies Inc. Buys 30,081 Shares of Dynavax Technologies Corporation $DVAX  MarketBeat

American Century Companies Inc. Buys 30,081 Shares of Dynavax Technologies Corporation $DVAX - MarketBeat

Click here to get full coverage on Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands - Stock Titan

Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands  Stock Titan

Dynavax Shareholders Face Critical Vote as 267% Returns Challenge Activist Demands - Stock Titan

Click here to get full coverage on Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good (NASDAQ:DVAX) - Seeking Alpha

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good (NASDAQ:DVAX)  Seeking Alpha

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good (NASDAQ:DVAX) - Seeking Alpha

Click here to get full coverage on We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve - simplywall.st

We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve  simplywall.st

We Think Dynavax Technologies' (NASDAQ:DVAX) Profit Is Only A Baseline For What They Can Achieve - simplywall.st

Click here to get full coverage on 14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms - Stock Titan

14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms  Stock Titan

14% Shareholder Battles Dynavax Board: Settlement Rejected, Proxy Fight Looms - Stock Titan

Click here to get full coverage on Chart Watch: Can DVAX outperform under higher oil prices - July 2025 Macro Moves & Community Consensus Trade Alerts - خودرو بانک

Chart Watch: Can DVAX outperform under higher oil prices - July 2025 Macro Moves & Community Consensus Trade Alerts  خودرو بانک

Chart Watch: Can DVAX outperform under higher oil prices - July 2025 Macro Moves & Community Consensus Trade Alerts - خودرو بانک

Click here to get full coverage on Update Report: Can DVAX outperform under higher oil prices - July 2025 Analyst Calls & Expert-Curated Trade Recommendations - خودرو بانک

Update Report: Can DVAX outperform under higher oil prices - July 2025 Analyst Calls & Expert-Curated Trade Recommendations  خودرو بانک

Update Report: Can DVAX outperform under higher oil prices - July 2025 Analyst Calls & Expert-Curated Trade Recommendations - خودرو بانک

Click here to get full coverage on High Growth Tech Stocks to Watch in the US July 2025 - simplywall.st

High Growth Tech Stocks to Watch in the US July 2025  simplywall.st

High Growth Tech Stocks to Watch in the US July 2025 - simplywall.st

Click here to get full coverage on Dynavax Comments on Glass Lewis Recommendation - PR Newswire

Dynavax Comments on Glass Lewis Recommendation  PR Newswire

Dynavax Comments on Glass Lewis Recommendation - PR Newswire

Click here to get full coverage on Citizens JMP Sticks to Their Buy Rating for Dynavax (DVAX) - The Globe and Mail

Citizens JMP Sticks to Their Buy Rating for Dynavax (DVAX)  The Globe and Mail

Citizens JMP Sticks to Their Buy Rating for Dynavax (DVAX) - The Globe and Mail

Click here to get full coverage on Director Makes Bold Move with Major Dynavax Stock Purchase - TipRanks

Director Makes Bold Move with Major Dynavax Stock Purchase  TipRanks

Director Makes Bold Move with Major Dynavax Stock Purchase - TipRanks

Click here to get full coverage on Dynavax Technologies' (DVAX) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat

Dynavax Technologies' (DVAX) Market Outperform Rating Reaffirmed at JMP Securities  MarketBeat

Dynavax Technologies' (DVAX) Market Outperform Rating Reaffirmed at JMP Securities - MarketBeat

Click here to get full coverage on Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - PR Newswire

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value  PR Newswire

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value - PR Newswire

Click here to get full coverage on Dynavax Technologies (NASDAQ:DVAX) Director Scott Dunseth Myers Buys 3,800 Shares - MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Director Scott Dunseth Myers Buys 3,800 Shares  MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Director Scott Dunseth Myers Buys 3,800 Shares - MarketBeat

Click here to get full coverage on Dynavax (DVAX) Gets a Buy from TD Cowen - The Globe and Mail

Dynavax (DVAX) Gets a Buy from TD Cowen  The Globe and Mail

Dynavax (DVAX) Gets a Buy from TD Cowen - The Globe and Mail

Click here to get full coverage on Deep Track Capital Comments on ISS Recommendation - Business Wire

Deep Track Capital Comments on ISS Recommendation  Business Wire

Deep Track Capital Comments on ISS Recommendation - Business Wire

Click here to get full coverage on Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting - Business Wire

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting  Business Wire

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting - Business Wire

Click here to get full coverage on Goldman Sachs Keeps Their Sell Rating on Dynavax (DVAX) - The Globe and Mail

Goldman Sachs Keeps Their Sell Rating on Dynavax (DVAX)  The Globe and Mail

Goldman Sachs Keeps Their Sell Rating on Dynavax (DVAX) - The Globe and Mail

Click here to get full coverage on Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study - Benzinga

Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study  Benzinga

Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study - Benzinga

Click here to get full coverage on SA analyst upgrades: NVDA, BABA, C, BA, SWKS, DVAX (NVDA:NASDAQ) - Seeking Alpha

SA analyst upgrades: NVDA, BABA, C, BA, SWKS, DVAX (NVDA:NASDAQ)  Seeking Alpha

SA analyst upgrades: NVDA, BABA, C, BA, SWKS, DVAX (NVDA:NASDAQ) - Seeking Alpha

Click here to get full coverage on Can Dynavax's New $225M Debt Deal Transform Its Financial Future? - Stock Titan

Can Dynavax's New $225M Debt Deal Transform Its Financial Future?  Stock Titan

Can Dynavax's New $225M Debt Deal Transform Its Financial Future? - Stock Titan

Click here to get full coverage on Dynavax stock holds steady as Citizens JMP reiterates Market Outperform rating - Investing.com

Dynavax stock holds steady as Citizens JMP reiterates Market Outperform rating  Investing.com

Dynavax stock holds steady as Citizens JMP reiterates Market Outperform rating - Investing.com

Click here to get full coverage on Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters

Dynavax elects all four of its nominees after Deep Track proxy fight  Reuters

Dynavax elects all four of its nominees after Deep Track proxy fight - Reuters

Click here to get full coverage on Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - Business Wire

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors  Business Wire

Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - Business Wire

Click here to get full coverage on Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share - Seeking Alpha

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share  Seeking Alpha

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share - Seeking Alpha

Click here to get full coverage on Insider Sale: President & COO of $DVAX Sells 14,020 Shares - Quiver Quantitative

Insider Sale: President & COO of $DVAX Sells 14,020 Shares  Quiver Quantitative

Insider Sale: President & COO of $DVAX Sells 14,020 Shares - Quiver Quantitative

Click here to get full coverage on TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛

TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25  富途牛牛

TD Cowen Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛

Click here to get full coverage on Dynavax reports positive results for shingles vaccine candidate - Investing.com

Dynavax reports positive results for shingles vaccine candidate  Investing.com

Dynavax reports positive results for shingles vaccine candidate - Investing.com

Click here to get full coverage on Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips - Investing.com

Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips  Investing.com

Earnings call transcript: Dynavax beats Q2 2025 forecasts, stock dips - Investing.com

Click here to get full coverage on Goldman Sachs reiterates Sell rating on Dynavax stock despite positive trial data - Investing.com

Goldman Sachs reiterates Sell rating on Dynavax stock despite positive trial data  Investing.com

Goldman Sachs reiterates Sell rating on Dynavax stock despite positive trial data - Investing.com

Click here to get full coverage on Dynavax stock rating reiterated at Market Outperform by Citizens JMP - Investing.com

Dynavax stock rating reiterated at Market Outperform by Citizens JMP  Investing.com

Dynavax stock rating reiterated at Market Outperform by Citizens JMP - Investing.com

Click here to get full coverage on Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX) - Seeking Alpha

Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX)  Seeking Alpha

Dynavax Technologies: Time To Refocus On Former Cash Cow CpG1018 (DVAX) - Seeking Alpha

Click here to get full coverage on Dynavax stock target cut to $31 by Citizens JMP - Investing.com

Dynavax stock target cut to $31 by Citizens JMP  Investing.com

Dynavax stock target cut to $31 by Citizens JMP - Investing.com

Click here to get full coverage on Dynavax Technologies: What The Stock Buyback Means, What It Doesn't (NASDAQ:DVAX) - Seeking Alpha

Dynavax Technologies: What The Stock Buyback Means, What It Doesn't (NASDAQ:DVAX)  Seeking Alpha

Dynavax Technologies Corporation (DVAX)

Price Chart

Key Statistics

Technicals

About DVAX

Latest News

Dynavax Technologies (NASDAQ:DVAX) Reaches New 52-Week Low - Here's What Happened - MarketBeat

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs - PR Newswire

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers